Asia - Pacific
China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use: Report
New protein-based vaccine to be used as booster jab, local media reports
Ahmet Gencturk |
03.09.2022 - Update : 05.09.2022
ANKARA
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.
